That was in relation to the Neo-POLEM PD1-Vaxx Ph2 that is (finally) due to start this half of the year.
3 doses every two weeks prior to surgery (which might be 2 weeks after the third dose). One of the aims of the trial is to see if the need for (extended) administration of MABS can be avoided.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)